[November 26, 2014]

Research and Markets: Global Regenerative Medicines Market 2014-2020 - Technology, Application and Geography Analysis of the $67 Billion Industry

Research and Markets (http://www.researchandmarkets.com/research/7wdlxm/global) has announced the addition of the "Global Regenerative Medicines Market 2014-2020 - Technology, Application and Geography Analysis of the $67 Billion Industry" report to their offering.

The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2%

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.

The factors driving growth of this market include advancements in stem cell therapy, significance of nanotechnology and increasing incidences of degenerative diseases. Stem cells have unique ability of proliferation and differentiation. These cells can differentiate into any celllineage. This distinctive characteristic of stem cells has made them of significant importance in this field. Additionally, the utilization of nano-materials in wound care, drug delivery and immunomodulation is opening growth avenues for the regenerative medicine market. However, the stringent regulations and the high cost of treatment act as hindrance for the progress of this market. The increasing focus on stem cells, their applications and the emerging economies would all contribute to the growth of this market. The developing nations are adopting technological advancements at a rapid pace, which would aid in the expansion of this market throughout the globe.

KEY BENEFITS

• The report provides an evaluation of drivers and restraints in this market, which would affect its growth. An assessment of opportunities is given to understand the growth avenues
• The technology segment helps in understanding the present technologies used in this market
• The application segment describes the availability of product based on type of diseases and discusses the ongoing studies for other disorders
• The segmentation based on geography helps in analyzing advancements in regenerative medicine market throughout the globe
• The projections in the report are made by analyzing the current market trends and future market potential for the period of 2013-2020
• The key strategies adopted by the market players are discussed to provide an insight on the winning approaches followed by the companies
• Porter's five forces analysis is used to assess the present industrial scenario to help stakeholders in making decisive moves

Scope of the Report

MARKET BY TECHNOLOGY

• Small molecules and Biologics
• Gene therapy
• Cell therapy

MARKET BY APPLICATION

• Dermatology
• Cardiovascular
• CNS
• Orthopedic
• Dental
• Others
• Autoimmune disorders
• Muscle regeneration
• Ocular diseases

Companies Mentioned

• Advanced Cell Technology
• Athersys Inc.
• Cytomedix
• Cytori Therapeutics
• Genzyme
• Kinetic Concepts
• Mesoblast Ltd.
• NuVasive
• Shire pharmaceuticals
• Stem Cells

For more information visit http://www.researchandmarkets.com/research/7wdlxm/global

[ Back To TMCnet.com's Homepage ]